Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma

PURPOSE: Gene-based immunotherapy for cancer is limited by the lack of safe, efficient, reproducible, and titratable delivery methods. Direct injection of DNA into tissue, although safer than viral vectors, suffers from low gene transfer efficiency. In vivo electroporation, in preclinical models, si...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Daud, Adil I., DeConti, Ronald C., Andrews, Stephanie, Urbas, Patricia, Riker, Adam I., Sondak, Vernon K., Munster, Pamela N., Sullivan, Daniel M., Ugen, Kenneth E., Messina, Jane L., Heller, Richard
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2008
Assuntos:
Immunotherapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2645111/
https://ncbi.nlm.nih.gov/pubmed/19029422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.15.6794
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados